Previous studies have shown that immunohistochemical analysis is superior to routine H&E assessment (17) and it is recommended to use at least three immunohistochemical markers such as synaptophysin, chromogranin, PGP 9.5 and cyclin-D1 to demonstrate tumor tissue (1,13,17). The gene discussed is CCND1; the disease is neoplasm.